EPS for Cronos Group Inc. (CRON) Expected At $-0.01

August 9, 2018 - By Billy Entrekin

Analysts expect Cronos Group Inc. (NASDAQ:CRON) to report $-0.01 EPS on August, 14 before the open.After having $-0.01 EPS previously, Cronos Group Inc.’s analysts see 0.00 % EPS growth. The stock increased 4.45% or $0.26 during the last trading session, reaching $6.03. About 1.33 million shares traded. Cronos Group Inc. (NASDAQ:CRON) has risen 244.25% since August 9, 2017 and is uptrending. It has outperformed by 231.68% the S&P500.

Cronos Group Inc., formerly known as PharmaCan Capital Corp., is a principal investment firm. The company has market cap of $1.07 billion. The firm seeks to invest in companies either licensed, or actively seeking a license, to produce medical marijuana pursuant to Canada's Marihuana for Medical Purposes Regulations . It has a 1004.5 P/E ratio. The firm typically invests in companies based in Canada.

More notable recent Cronos Group Inc. (NASDAQ:CRON) news were published by: Fool.com which released: “9 Ways Marijuana Has Made History This Year” on August 05, 2018, also Investorideas.com with their article: “Investor Ideas #Potcasts #Cannabis News and Stocks on the Move: TSX: WEED.TO, NYSE: $CGC, NADSAQ: $CRON …” published on August 09, 2018, Forbes.com published: “Cronos Group Earnings Preview: Looking For Updates On Capacity Expansion Plans” on August 07, 2018. More interesting news about Cronos Group Inc. (NASDAQ:CRON) were released by: Fool.com and their article: “Meet the Newest — and Hottest — Marijuana Stock on the Market” published on July 23, 2018 as well as Investorideas.com‘s news article titled: “Investor Ideas #Potcasts; #Cannabis News and Stocks on the Move; NASDAQ: $CRON, TSX: $EMC.TO, TSXV: $GENE …” with publication date: July 18, 2018.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.